Key Details
Price
$1.14Annual ROE
-51.91%Beta
0.93Events Calendar
Next earnings date:
Mar 28, 2025Recent quarterly earnings:
Nov 13, 2024Recent annual earnings:
Mar 28, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Feb 3, 25 JMP Securities
Market OutperformNov 19, 24 JMP Securities
Market OutperformNov 18, 24 TD Cowen
HoldAug 9, 24 JMP Securities
Market OutperformJul 3, 24 Leerink Partners
OutperformMay 16, 24 Evercore ISI Group
In-LineApr 2, 24 JMP Securities
Market OutperformApr 1, 24 Oppenheimer
PerformFeb 13, 24 Leerink Partners
Market PerformFeb 12, 24 Oppenheimer
PerformMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
AN2 Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for AN2 Therapeutics?
- Does AN2 Therapeutics pay dividends?
- What sector is AN2 Therapeutics in?
- What industry is AN2 Therapeutics in?
- What country is AN2 Therapeutics based in?
- When did AN2 Therapeutics go public?
- Is AN2 Therapeutics in the S&P 500?
- Is AN2 Therapeutics in the NASDAQ 100?
- Is AN2 Therapeutics in the Dow Jones?
- When was AN2 Therapeutics's last earnings report?
- When does AN2 Therapeutics report earnings?
- Should I buy AN2 Therapeutics stock now?
What is the ticker symbol for AN2 Therapeutics?
The ticker symbol for AN2 Therapeutics is NASDAQ:ANTX
Does AN2 Therapeutics pay dividends?
No, AN2 Therapeutics does not pay dividends
What sector is AN2 Therapeutics in?
AN2 Therapeutics is in the Healthcare sector
What industry is AN2 Therapeutics in?
AN2 Therapeutics is in the Biotechnology industry
What country is AN2 Therapeutics based in?
AN2 Therapeutics is headquartered in United States
When did AN2 Therapeutics go public?
AN2 Therapeutics's initial public offering (IPO) was on March 25, 2022
Is AN2 Therapeutics in the S&P 500?
No, AN2 Therapeutics is not included in the S&P 500 index
Is AN2 Therapeutics in the NASDAQ 100?
No, AN2 Therapeutics is not included in the NASDAQ 100 index
Is AN2 Therapeutics in the Dow Jones?
No, AN2 Therapeutics is not included in the Dow Jones index
When was AN2 Therapeutics's last earnings report?
AN2 Therapeutics's most recent earnings report was on Nov 13, 2024
When does AN2 Therapeutics report earnings?
The next expected earnings date for AN2 Therapeutics is Mar 28, 2025
Should I buy AN2 Therapeutics stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions